ACH
ArrowMark Colorado Holdings Portfolio holdings
AUM
$5.55B
1-Year Return
17.42%
This Quarter Return
+15.23%
1 Year Return
+17.42%
3 Year Return
+73.67%
5 Year Return
+135.73%
10 Year Return
+381.42%
AUM
$9.06B
AUM Growth
+$842M
(+10%)
Cap. Flow
-$145M
Cap. Flow
% of AUM
-1.6%
Top 10 Holdings %
Top 10 Hldgs %
24.16%
Holding
330
New
23
Increased
115
Reduced
72
Closed
23
Top Buys
| 1 |
Merit Medical Systems
MMSI
|
$47.6M |
| 2 |
Align Technology
ALGN
|
$42.3M |
| 3 |
Tandem Diabetes Care
TNDM
|
$38.6M |
| 4 |
Doximity
DOCS
|
$38.5M |
| 5 |
Trimble
TRMB
|
$35.7M |
Top Sells
| 1 |
Henry Schein
HSIC
|
$101M |
| 2 |
Tennant Co
TNC
|
$73.2M |
| 3 |
Skechers
SKX
|
$61.8M |
| 4 |
Grand Canyon Education
LOPE
|
$56.9M |
| 5 |
GOOS
Canada Goose Holdings
GOOS
|
$56M |
Sector Composition
| 1 | Healthcare | 26.48% |
| 2 | Technology | 23.62% |
| 3 | Industrials | 15.23% |
| 4 | Consumer Discretionary | 14.47% |
| 5 | Communication Services | 7.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Clarivate
CLVT
$2.96B
| $5.09M | 0.06% |
550,000
-91,000
| -14% | -$843K |
|
202
Pliant Therapeutics
PLRX
$114M
| $5.09M | 0.06% |
281,189
| – | – |
|
203
Dyne Therapeutics
DYN
$2.02B
| $5.09M | 0.06% |
382,416
| – | – |
|
204
HEICO Class A
HEI.A
$35.1B
| $5.08M | 0.06% |
35,667
-1
| -0% | -$142 |
|
205
CS Disco
LAW
$344M
| $4.94M | 0.05% |
+650,982
| New | +$4.94M |
|
206
nLIGHT
LASR
$1.44B
| $4.86M | 0.05% |
360,000
+20,000
| +6% | +$270K |
|
207
Weyerhaeuser
WY
$18.9B
| $4.82M | 0.05% |
138,710
| – | – |
|
208
American Superconductor
AMSC
$2.21B
| $4.81M | 0.05% |
431,432
+50,000
| +13% | +$557K |
|
209
Liberty Media Series C
FWONK
$25.2B
| $4.74M | 0.05% |
75,108
| – | – |
|
210
Boston Omaha
BOC
$425M
| $4.72M | 0.05% |
299,883
+100
| +0% | +$1.57K |
|
211
KKR & Co
KKR
$121B
| $4.51M | 0.05% |
54,400
| – | – |
|
212
BridgeBio Pharma
BBIO
$10.2B
| $4.44M | 0.05% |
110,011
| – | – |
|
213
Navitas Semiconductor
NVTS
$1.19B
| $4.42M | 0.05% |
548,000
| – | – |
|
|
CBAY
214
DELISTED
Cymabay Therapeutics
CBAY
| $4.24M | 0.05% |
179,400
| – | – |
|
215
EVI Industries
EVI
$362M
| $4.15M | 0.05% |
174,922
-72,452
| -29% | -$1.72M |
|
216
Ambarella
AMBA
$3.54B
| $3.98M | 0.04% |
65,000
-11,000
| -14% | -$674K |
|
217
VSE Corp
VSEC
$3.44B
| $3.88M | 0.04% |
60,000
| – | – |
|
218
Nurix Therapeutics
NRIX
$758M
| $3.25M | 0.04% |
314,762
| – | – |
|
219
Liberty Global Class A
LBTYA
$4.05B
| $3.22M | 0.04% |
181,200
| – | – |
|
220
Planet Labs
PL
$1.98B
| $3.15M | 0.03% |
1,274,000
+347,000
| +37% | +$857K |
|
221
Constellium
CSTM
$2.04B
| $3.13M | 0.03% |
+156,913
| New | +$3.13M |
|
222
Immunovant
IMVT
$2.99B
| $3.1M | 0.03% |
73,550
| – | – |
|
|
LSXMA
223
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $3.09M | 0.03% |
107,478
| – | – |
|
224
NVIDIA
NVDA
$4.07T
| $3.08M | 0.03% |
62,220
-60,000
| -49% | -$2.97M |
|
225
Digital Turbine
APPS
$483M
| $2.95M | 0.03% |
429,389
| – | – |
|